195 related articles for article (PubMed ID: 33196513)
1. Difficulty in controlling heavy menstrual bleeding at menarche in a patient with Glanzmann's thrombasthenia.
Kadowaki S; Makino S; Mohri Y; Awaguni H; Shinozuka J; Imashuku S
Blood Coagul Fibrinolysis; 2021 Mar; 32(2):155-158. PubMed ID: 33196513
[TBL] [Abstract][Full Text] [Related]
2. Severe juvenile vaginal bleeding due to Glanzmann's thrombasthenia: case report and review of the literature.
Markovitch O; Ellis M; Holzinger M; Goldberger S; Beyth Y
Am J Hematol; 1998 Mar; 57(3):225-7. PubMed ID: 9495374
[TBL] [Abstract][Full Text] [Related]
3. Control of severe bleeding episode in case of Glanzmann's thrombasthenia refractory to platelet transfusion therapy by administering recombinant factor VIIa.
Javed A; Ayyub M; Abrar S; Mansoor M; Khan B; Hussain T
J Ayub Med Coll Abbottabad; 2009; 21(2):171-3. PubMed ID: 20524499
[TBL] [Abstract][Full Text] [Related]
4. NovoSeven (recombinant factor VIIa) for the treatment of bleeding episodes and perioperative management in patients with Glanzmann's thrombasthenia.
Franchini M; Lippi G
Expert Rev Hematol; 2014 Dec; 7(6):733-40. PubMed ID: 25387838
[TBL] [Abstract][Full Text] [Related]
5. The use of recombinant factor VIla in a primigravida with Glanzmann's thrombasthenia during delivery.
Kale A; Bayhan G; Yalinkaya A; Yayla M
J Perinat Med; 2004; 32(5):456-8. PubMed ID: 15493726
[TBL] [Abstract][Full Text] [Related]
6. Perioperative management of a pediatric patient with Glanzmann's thrombasthenia during adenoidectomy.
Duman EN; Saylan S; Cekic B
Rev Bras Anestesiol; 2012 Jul; 62(4):548-53. PubMed ID: 22793971
[TBL] [Abstract][Full Text] [Related]
7. [Life threatening menorrhagia in thrombasthenia. (Glanzmann-Naegeli) thrombasthenia].
Schnell K; Merkle E; Klinge J; Berger K; Dörr HG; Wenzel D
Monatsschr Kinderheilkd; 1992 Jan; 140(1):24-6. PubMed ID: 1565104
[TBL] [Abstract][Full Text] [Related]
8. The use of recombinant FVIIa in a patient with Glanzmann thrombasthenia with uncontrolled bleeding after tonsillectomy.
Erduran E; Aksoy A; Zaman D
Blood Coagul Fibrinolysis; 2009 Apr; 20(3):215-7. PubMed ID: 19657319
[TBL] [Abstract][Full Text] [Related]
9. Successful surgery using recombinant factor VIIa for recurrent, idiopathic nonulcer duodenal bleeding in a patient with Glanzmann's thrombasthenia.
van Buuren HR; Wielenga JJ
Dig Dis Sci; 2002 Sep; 47(9):2134-6. PubMed ID: 12353868
[TBL] [Abstract][Full Text] [Related]
10. Glanzmann's thrombasthenia: a rare bleeding disorder in a Nigerian girl.
Ezenwosu OU; Chukwu BF; Uwaezuoke NA; Ezenwosu IL; Ikefuna AN; Emodi IJ
Afr Health Sci; 2020 Jun; 20(2):753-757. PubMed ID: 33163040
[TBL] [Abstract][Full Text] [Related]
11. The Use of Recombinant Activated Factor VII in Patients with Glanzmann's Thrombasthenia.
Poon MC
Thromb Haemost; 2021 Mar; 121(3):332-340. PubMed ID: 33124022
[TBL] [Abstract][Full Text] [Related]
12. Independent adjudicator assessments of platelet refractoriness and rFVIIa efficacy in bleeding episodes and surgeries from the multinational Glanzmann's thrombasthenia registry.
Recht M; Rajpurkar M; Chitlur M; d'Oiron R; Zotz R; Di Minno G; Cooper DL; Poon MC
Am J Hematol; 2017 Jul; 92(7):646-652. PubMed ID: 28370369
[TBL] [Abstract][Full Text] [Related]
13. Recombinant activated factor VII combined with desmopressin in preventing bleeding from dental extraction in a patient with Glanzmann's thrombasthenia.
Lombardo VT; Sottilotta G
Clin Appl Thromb Hemost; 2006 Jan; 12(1):115-6. PubMed ID: 16444446
[TBL] [Abstract][Full Text] [Related]
14. Use of recombinant activated factor VII in patients with Glanzmann's thrombasthenia: a review of the literature.
Rajpurkar M; Chitlur M; Recht M; Cooper DL
Haemophilia; 2014 Jul; 20(4):464-71. PubMed ID: 24948404
[TBL] [Abstract][Full Text] [Related]
15. Dental considerations for a Glanzmann's thrombasthenia patient: case report.
Bisch FC; Bowen KJ; Hanson BS; Kudryk VL; Billman MA
J Periodontol; 1996 May; 67(5):536-40. PubMed ID: 8724714
[TBL] [Abstract][Full Text] [Related]
16. Surgical procedures in patients with Glanzmann's thrombasthenia: case series and literature review.
Ganapule A; Jain P; Abubacker FN; Korula A; Abraham A; Mammen J; George B; Mathews V; Srivastava A; Viswabandya A
Blood Coagul Fibrinolysis; 2017 Mar; 28(2):171-175. PubMed ID: 27273143
[TBL] [Abstract][Full Text] [Related]
17. Intensive menstrual bleeding successfully treated with recombinant factor VIIa in Glanzmann thrombasthenia.
Balci YI; Karabulut A; Kabukcu S; Sari I; Keskin A
Clin Appl Thromb Hemost; 2011 Aug; 17(4):320-2. PubMed ID: 20460355
[TBL] [Abstract][Full Text] [Related]
18. Prophylactic and therapeutic recombinant factor VIIa administration to patients with Glanzmann's thrombasthenia: results of an international survey.
Poon MC; D'Oiron R; Von Depka M; Khair K; Négrier C; Karafoulidou A; Huth-Kuehne A; Morfini M;
J Thromb Haemost; 2004 Jul; 2(7):1096-103. PubMed ID: 15219192
[TBL] [Abstract][Full Text] [Related]
19. New Insights Into the Treatment of Glanzmann Thrombasthenia.
Poon MC; Di Minno G; d'Oiron R; Zotz R
Transfus Med Rev; 2016 Apr; 30(2):92-9. PubMed ID: 26968829
[TBL] [Abstract][Full Text] [Related]
20. Clinical use of recombinant human activated factor VII (rFVIIa) in the prevention and treatment of bleeding episodes in patients with Glanzmann's thrombasthenia.
Poon MC
Vasc Health Risk Manag; 2007; 3(5):655-64. PubMed ID: 18078017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
